Next Article in Journal
Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
Previous Article in Journal
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 22
10.3390/ijms222212294
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Metal Sulfide Semiconductor Nanomaterials and Polymer Microgels for Biomedical Applications

by
Athandwe M. Paca
and
Peter A. Ajibade
*
School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3209, South Africa
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(22), 12294; https://doi.org/10.3390/ijms222212294
Submission received: 21 October 2021 / Revised: 7 November 2021 / Accepted: 10 November 2021 / Published: 14 November 2021
(This article belongs to the Section Materials Science)
Browse Figures
Versions Notes

Abstract

:
The development of nanomaterials with therapeutic and/or diagnostic properties has been an active area of research in biomedical sciences over the past decade. Nanomaterials have been identified as significant medical tools with potential therapeutic and diagnostic capabilities that are practically impossible to accomplish using larger molecules or bulk materials. Fabrication of nanomaterials is the most effective platform to engineer therapeutic agents and delivery systems for the treatment of cancer. This is mostly due to the high selectivity of nanomaterials for cancerous cells, which is attributable to the porous morphology of tumour cells which allows nanomaterials to accumulate more in tumour cells more than in normal cells. Nanomaterials can be used as potential drug delivery systems since they exist in similar scale as proteins. The unique properties of nanomaterials have drawn a lot of interest from researchers in search of new chemotherapeutic treatment for cancer. Metal sulfide nanomaterials have emerged as the most used frameworks in the past decade, but they tend to aggregate because of their high surface energy which triggers the thermodynamically favoured interaction. Stabilizing agents such as polymer and microgels have been utilized to inhibit the particles from any aggregations. In this review, we explore the development of metal sulfide polymer/microgel nanocomposites as therapeutic agents against cancerous cells.

1. Introduction

The search for new therapeutic agents to treat cancer is an active research area because cancer remained one of the public health problems in the world. In the search for novel therapeutic agents, development of nanomaterials has become one of the most effective platforms to fabricate novel therapeutic agents and delivery systems to treat cancer [1]. This is mostly due to the high selectivity of nanomaterials for cancer cells that is associated with the porous nature of tumour cells which allows nanomaterials to accumulate more in tumour cells than in normal cells. Nanomaterials are low dimensional structures with at least one dimension less than 100 nm which confers on these material’s unique properties. These materials could be classified as one dimensional, two dimensional or three dimensional, based on their size and the number of dimensions that are quantum confined [2]. Nanomaterials result from nanotechnology which is a combination of technology and science that functions at nanoscale level to provide novel properties as well as novel applications. The principle of nanotechnology is the capability to design and engineer materials and frameworks in the nanometer range with novel properties for unique applications.
As the particle size gets smaller, the surface-to-volume ratio gets larger and leads to an increase in the rate of any reactions which take place on the surface of the materials as more surface atoms are subject to reaction. Moreover, as particles become smaller, the extent of particles on the surface increases similar to those inside, which results in extraordinary properties for the as-prepared materials [3,4,5]. In addition, as the size of the nanomaterial decreases, quantum effects start to regulate the behaviour and inherent properties of the materials. This is a result of limited electron motion as electron become spatially restrained and give rise to electronic and thermodynamic properties that diverge from those of the mass structure [4]. The physical and chemical attributes (such as chemical reactivity, absorption, emission, and biological mobility) are transformed when the material dimensions move toward the de Broglie wavelength. However, as the size of particles become smaller, the resulting nanomaterials possess striking optical and electronic properties which lead to innovative applications in a wide spectrum of fields.
Morphological properties like size and shape play a huge role in the properties of nanomaterials. The size and particle dispersal are of paramount importance in the electronic, thermodynamic, and chemical properties of the material. The particle size of material influences the structure, lattice parameters, and crystalline nature of any nanomaterial. Nanomaterials with smaller particle size have larger surface area [6]. In the course of synthesis of nanomaterials, the synthetic approach used dictates the shapes (spheres, cubic, tubes, rods, etc.) of the resulting materials [7]. Shapes of nanomaterials are significant in biomedical application such as chemotherapy [8]. Properties such as colour and transparency are a consequence of the optical properties. These properties normally change at a nano-level since nanomaterials are so small that the movement if the electrons in them is restricted, which results in nanomaterials reacting differently with light as compared to bulk materials. Metal sulfide nanomaterials have been investigated owing to their different crystalline structures [9]. Metal sulfide nanomaterials involve sulfur atoms chemically bonded to metal ions [10]. They represent a major group of minerals with various structural phases with the general formula MxSy [11,12]. Metal sulfides are naturally versatile compounds compared to metal oxides due to the smaller electronegativity of sulfur compared to oxygen [13]. Thus, it is necessary to review the impact of polymer-based microgel semiconductor metal sulfide nanomaterials as diagnostic tools and therapeutic agents which may offer new opportunities for application in cancer therapy.

2. Synthesis of Nanomaterials

The structural attributes of nanomaterials are the most important properties that influences the functional properties and applications of the materials. In order to get the distinctive properties such as the different sizes, shapes, and compositions of nanomaterials, one need to use good synthetic approaches that will give the as-prepared nanomaterials unique properties. Various procedures have been used to prepare nanomaterials and some of them are described below:

2.1. The Sol-Gel Method

Small molecules are combined to produce solid nanomaterial with varying shapes. This involves two different phases, namely solution and gelatin (solid) which can be easily separated [14]. This method permits the formation of solid materials and can be utilized to fabricate nanomaterials in different morphologies for various applications [14]. This approach can yield nanostructured materials with high purity and uniform size distributions at low temperatures [15]. This method is mostly used to prepare metal oxide nanomaterials [16,17,18,19]

2.2. Hydrothermal/Solvothermal Method

In this method, the synthesis of the nanomaterials is performed in sealed vessel in which the temperature of the solvents can be brought to around their boiling points through heating simultaneously under adequate pressures. This process is called hydrothermal when water is used and solvothermal when organic solvents are used in the synthesis [20].

2.3. Vacuum Deposition Method

This method requires an inert gas in vacuum chamber for the preparation of the nanomaterials. During preparation, the temperature of the substrate gets lowered down to −196 ° (77.15 K). Through thermal evaporation, the momentum of the vaporized metallic atoms can be reduced by gas to prevent their agglomeration on the substrate. The evaporated metal atoms get deposited on the layers of the evaporation chamber and the particle sizes can be effectively regulated between 3∼100 nm depending on the reaction conditions such that the temperature of the substrate, evaporation speed, gas pressure and the nature of the gas utilized [15].

2.4. Ball Milling Method

This method requires no solvent, it employs simple grinding of the powders together till the required nano-sized alloy is obtained [21]. Hard and fragile ceramic structures can be processed into nanomaterials to give nanocrystals and pseudo-crystals. An addition of approximately 2% of an alcohol can inhibit the dispersion and solid reaction of the nanoparticles [15].

2.5. Thermolysis

This method is acknowledged for the preparation of metal sulfide nanoparticles. The morphology and purity of the nanoparticles can be regulated by varying the reaction conditions such as the nature of the single-precursor molecule [22,23,24], decomposition temperature [25,26], duration of the thermolysis and capping agents [27,28]. Briefly, during this process (Scheme 1), a single-source precursor molecule dispersed in a particular solvent gets injected into a high boiling point coordinating solvents (capping agents) in an inert environment [29]. This method is quite useful as it permits simple control of the relative intensities of the excitonic shortwave against the surface state longwave emission [30]. Khan et al. [31] synthesized spherically-shaped HgS nanoparticles by the thermal decomposition of Hg(II) dithiocarbamate complexes. Arandhara and colleagues [32] thermolyzed ZnS nanoparticles and varied the thermolysis temperature to investigate the generated changes in the growth process. They discovered that at temperatures above 200 °C, thin films with high crystallinity were produced. Ain et al. [33] prepared highly crystalline octylamine- capped CuS nanoplates by thermolysis of Cu(II) dithiocarbamate. The authors noted that these nanoplates have good catalytic efficiency and photocatalytic performance.

3. Nanomaterials in Biomedicine

In the context of biomedicine, nanoparticles could improve the intracellular concentration of drugs in tumorous cells without any effect on normal cells. They normally do this by bypassing the P-glycoprotein, the main drug resistance mediator [34]. Another advantage is that vital building blocks of life such as DNA and proteins fall within the nanometer range (Figure 1). For instance, double stranded DNA has intra-strand with spacing of approximately 2 nm while cell membranes have a thickness of about 10 nm. Haemoglobin has a diameter around 5.5 nm and insulin is about 3 nm in diameter [35]. New therapeutic and diagnostic nanomaterials fabricated with at least one dimension in the nanometer range exhibit physicochemical properties that induce host reactions at a biomolecular level that are different from those of their bulk forms. They provide notable advantages over conventional systems such as improved and regulated delivery, prolonged drug bioactivity, enhanced circulation times and greater dissolution rates [36]. These nanomaterials are at present being used for different biomedical applications as shown in Figure 2.

Metal Sulfide Nanomaterials in Cancer Therapy

These are semiconductor materials with various applications in biomedicine that are attributable to their distinctive properties at the nanometer scale, such as their absorption in the infrared region which result in a narrow optical band gap, high fluorescence, structural and thermal steadiness [37,38], water-dispersibility, non-toxicity, exceptional catalytic and photocatalytic activity and electric conductivity [39,40]. To date, these semiconductor nanomaterials are being developed for therapeutic applications due to their peculiar physical and chemical attributes [41]. Typically, metal sulfide semiconductor materials are perfect species for the development of chemotherapeutic agents owing to their robust near-infrared (NIR) absorbance, minimal toxicity and good photochemical degradation [42]. Metal sulfide nanomaterials have been fabricated for the therapeutic and diagnosis of cancer. They have been used as diagnostic tools in photoacoustic [43,44] and multimodal imaging [45,46]. Photothermal therapy [47], photodynamic therapy [48], radiotherapy [49] and chemotherapy [50] for cancer treatment. Metal sulfide nanomaterials are promising frameworks in cancer photothermal therapy because of their elevated absorbance in the NIR region.
Ruthenium sulfide is among the group of transition metal chalcogenides that are being explore as potential therapeutic agents [51,52]. Lu et al. [53] prepared novel photothermal agents, ruthenium sulfide-based (PEG-dBSA-RuS1.7) nanoclusters. Firstly, RuS1.7 nanodots were prepared by the decomposition of tris(diethyldithiocarbamato)ruthenium(III) ([Ru(DDTC)3]) (Figure 3) in oleic acid and ethyl alcohol. The resulting as-prepared nanorods showed a uniform particle size with an average particle size of 1.5 nm (Figure 4a). These nanodots were then coated with denatured bovine serum albmin (dBSA) and poly(ethyleneglycol) (PEG) to form water soluble nanoclusters with an average size of 23 nm as illustrated in Figure 4b, a suitable size for photothermal application. These photothermal agents exhibited great physiological stabilities, notable photothermal properties on NIR laser irradiation, outstanding biocompatibility, and very low toxicity. Noteworthy, the in vivo chemotherapeutic studies showed that these nanomaterials have a prolonged blood circulation and tumour accumulation in comparison to other photothermal agents.
Xie and colleagues [54] designed dual-function tin sulfide (SnS) nanosheets and applied them in cancer theranostics. They synthesized the nanosheets from bulk SnS and functionalized them with targeting and imaging agents. The SnS nanosheets exhibited good biocompatibility and effective photothermal activity. Moreover, steady photothermal performance over brief times of laser irradiation and photodegradability over extended exposure was observed. As a result of their morphology, they showed high loading of small molecules that confirm their capability as drug carrier. The in vitro and in vivo experiments showed improved anticancer activity with no noticeable side effects and toxicity to healthy cells.
Lu et al. [55] fabricated a stimuli-responsive nanocomposites made up of copper sulfide (CuS) nanoparticles and graphene oxide (GO) nanosheets to act as carrier for the distribution of doxorubicin (DOX) for thermal chemotherapy. The nanoparticles acted as delivery system for DOX molecules and GO nanosheets prevented the leakage of drug and improved photothermal energy conversion efficacy. The CuS-DOX/GO nanocomposites were fabricated in such a way that they discharge the DOX in response to pH and near-infrared light stimuli, making the therapeutic effect to be well-regulated which led to high specificity. The in vitro cytotoxicity against HeLa cells proved that the CuS-DOX/GO nanocomposites are potential therapeutic and delivery systems. Hou and associates [56] devised a dual-function tumour targeted CuS nanoparticles which could serve as drug carrier and photoacoustic imaging agent to direct photo-chemotherapy. Cytotoxic evaluation showed that the system sustained a high intracellular drug concentration within tumour cells, resulting in improved therapeutic effect.

4. Drug Delivery

Drug delivery refers to the administration of pharmacological drugs into the body to accomplish its anticipated therapeutic effect. Drug delivery has been broadly studied. It involves a wide spectrum of techniques used to administer therapeutics in the body [57]. The most important trait of any drug delivery material is its aptitude to control the release, minimalize the side effects and expand the therapeutic efficiency of drugs [58]. Kheirandish and colleagues [59] prepared ruthenium sulfide nanoparticles encapsulated in chitosan (RuS2-NPs-CS) nanocomposites as an effective in vitro delivery system for curcumin and antibacterial agents. The results revealed that incorporation of RuS2 nanoparticles into chitosan provided a potential drug carrier with high drug loading and release efficiency. These nanocomposites also showed antibacterial activity against Pseudomonas aeruginosa (PAO-)1 bacterial.
The use of polymers as drug delivery system can curb many of the drawbacks posed by free therapeutic agents, such as poor stability, solubility, biodistribution and pharmacokinetics, rapid degradation and non-specific toxicity [60,61]. Drug delivery systems can be constructed to afford regulated drug release with minimum unfavourable side effects [62,63]. Polymers play a vital role in our everyday lives. A polymer is a molecule consisting of several repetitive subunits. Our bodies are made up of biomolecules such as proteins and nucleic acid which are in fact polymeric. All biological processes are regulated by many factors because of changes in stimuli. Synthetic polymers that are stimuli responsive find application in biomedicine due to their capability to mimic biomolecules. They are used as therapeutic agents, biosensors, and drug delivery systems especially for cancer. Synthetic polymers show better pharmacokinetics such as longer circulation time and reduced toxicity [64]. Polymers are also better drug delivery systems because of their tunable properties which allow regulated release of encapsulated drug within the polymer.
Drug delivery to patients is best physiologically suitable way that has constantly been a major challenge for a very long time [65]. Better consideration of changes in the environment of pathological tissues, has enabled for the development of new materials capable of reacting particularly to specific “peculiar” conditions of affected tissues [66]. Some polymers can undergo particular changes in their physiochemical properties as a reaction to changes in their surroundings, that can be manipulated to design stimuli-responsive delivery systems [66]. Thermo-responsive polymeric systems have been used to design temperature responsive drug delivery systems which have critical transition temperature [67]. Since, tumour cells are normally distinguished by higher temperature than the normal cells, the temperature difference may possibly help to formulate thermos-responsive drug delivery systems [68].

4.1. Polymer Microgels as Drug Delivery Systems

Among synthetic polymers, microgels has emerge as the most interesting group of polymers. Microgels are units of gel with a diameter of about 50 nm to 10 µm. They are cross-linked macromolecules with high molecular weight and possess a globular shape. Microgels exhibit various significant properties such as tunable structure, porous nature and modifiable dimensions [69]. They have an ability to undergo rapid volume phase transitions. In other words, they can swell and de-swell through different environmental inducement such as change in temperature, ionic strength, and pH. They can be easily synthesized and the synthetic technique used influences essential properties such as the size and functionality, which are significant, specifically for regulating drug loading and release dynamics, durability, biodistribution and biocompatibility, degradation and bioaccumulation, and functionality in the perspective of a drug delivery purposes [70]. Microgels are currently being investigated and find applications in cosmetics, surface coatings, catalysis, and drug delivery. Polymer microgels have emerged as good delivery vehicles for metal nanoparticles due to their distinct properties that are suitable for the conditions of drug vehicles used via systematic routes of administration [71]. Microgels have high water content and desirable mechanical properties. The size of microgel is tunable from nanometers to micrometers hence they are significant tools for polymer-based delivery frameworks [72].
Microgels have received tremendous attention for the development of drug delivery system. This is because of their capability to deliver therapeutic agents particularly to tumorous tissues and consequently reduce side effects that result from unintended delivery to healthy tissues [65]. Also, aqueous microgel are highly hydrophilic with low interfacial energy in a biological medium which result in and lowered nonspecific interactions with proteins and accumulative bioavailability and biocompatibility. The core microgels permits the potential integration of fairly big quantities of drugs [65].
Microgels offer a convenient to control the surface morphologies which could be used to maneuver the structures at a nanometer to micrometer scale [73]. This enables the incorporation of other novel materials with specific functional groups to control their dispersity within the microgel [73,74]. Microgels offer various advantages such as easy preparation, tunable degree of cross-linking, colloidal stability, and stimulus response. These properties allow incorporation of nanoparticles within the microgel. Incorporation of nanoparticle can be achieved by three methods [75]. The first method uses the microgel as a template for in situ preparation of inorganic nanoparticles [76]. The second method involves diffusion of the as-prepared nanoparticles into the microgel [77]. The third method involves the fusion of the as-prepared nanoparticles with reactive surfaces in microgels straight for the duration of the synthesis. This route result in effective incorporation and rigid bonding of the nanoparticles by covalent bonds in microgel system to inhibit nanoparticle outflow [78].
Microgels made from poly(N-isopropylacrylamide) (PNIPAM) [79], poly(vinylcaprolactam) (PVCL) [80] and poly(oligo(ethyleneglycol)methacrylate) (POEGMA) [81] shown in Figure 5a, have lower critical solution temperature (LCST) in aqueous medium and precipitate from solution when heated to a temperature beyond their LCST. PNIPAM was first synthesized in the 1950s and is the most common thermos-responsive polymer used in drug delivery systems [82]. PNINAM exhibits reversible phase transition upon heating and becomes poorly soluble in water as the temperature of the solution rises. It has a distinct structure and its thermal response is close to that of the human body [83,84]. It has LCST of 32 °C, and at any temperature lower than this, it becomes hydrophilic and water soluble due to the hydrogen-bonding interactions which results in a coil-like conformation. Above the LCST, it becomes very hydrophobic and forms a viscous gel which stick to tissues. PNIPAM has been used to prepare microgel for therapeutic targets such as in drug targeting for tumour, in drug delivery and in tissue engineering [82,85]. PNIPAM microgels are acknowledged drug delivery systems as they tend to shrink above their volume-phase transition temperature (VPTT) and release any molecules present within the microgel (Figure 5b) [86].
Core-shell microgels consist of a hydrophobic core and a hydrophilic shell. The characteristics of the core and the shell may be combined to produce decent drug delivery systems. Metal-containing microgels are being developed as therapeutic and diagnostic tools. They have been employed as the main templates for the preparation of metal nanomaterials incorporated into polymer matrix [71]. Wu et al. [58] prepared core-shell hybrid nanogels consisting of Ag nanoparticles as core and poly(N-isopropylacrylamide-co-acrylic acid) (PNIPAM-co-AA) gel as shell and investigated the cell imaging and pH-controlled drug delivery with optimum drug stacking capability. PNIPAM-co-AA gel shell can expand and shrink because of pH adjustment. This manipulates the properties of the incorporated nanoparticles and modifies the size of the gel shell to control the way in which the drug is being discharged. pH-responsive microgels possess properties such adjustable size, large surface area for conjugation of biomolecules, internal network arrangement for integration of drugs, reduced undesired impacts of drugs and regulated drug release at a precise pH surrounding [72]. Several pH-responsive polymer microgels have been developed and incorporated with bioactive molecules such as drugs for regulated release [87,88,89]. The pH-responsive hybrid microgels are tunable delivery systems for specific purposes when they go through local stimuli in pursuit of the affected area such as tumour cells that are characterized by alterations in acid or base equilibrium [90,91,92].
Muratalin and colleagues prepared functionalized PNIPAM microgels using the emulsion polymerization synthetic route. The microgels showed stimuli response to changes such as change in temperature, pH and introduction of copper(II) ions and glucose. The stimuli response of the microgels and VPTT which is similar to that of the human body made these microgels suitable drug delivery platforms that can be controlled by external stimuli [93]. Recently, Khan and co-workers reported a multi-responsive poly(N-isopropylacrylamide-allyl acetic acid) (PNIPAM-AAA) copolymer microgel loaded with CuO nanoparticles. The results demonstrated that the hybrid microgels filled with nanoparticles possess notable antibacterial activity [94]. Zhang et al. [76] synthesized nanoparticles using microgels as a template and investigated their magnetic properties. The results showed that the properties of nanoparticles depend on the framework and structural hierarchy of microgels, and conditions used for the preparation. These hybrid microgels have promising applications in catalysis, medicine, and chemical separation technologies.

4.2. Synthesis of Microgels

The synthesis of microgels involves regulating some important characteristics properties for the microgel to be able to perform significant functions. It is important to regulate the size and particle size dispersity of microgel particles throughout the preparation process. Thermo-responsive microgels are mostly made by precipitation and inverse emulsion polymerization [95].

Precipitation Polymerization Method

This method is the generally preferred synthetic route for the preparation of aqueous microgels. It is mostly used for the preparation of thermo-sensitive microgels [96]. It regulates the extent of cross-linking, functionality, and the microgel size and size distributions. Complex compounds such as core-shell microgels, can be formulated by using metallic nanoparticles or microgels as nucleation points equivalent to the parent particles [70]. During precipitation polymerization, an aqueous solution of the monomer, cross-linker and surfactant gets heated beyond the LCST of the polymer, and then a free radical initiator is added [70]. The resultant polymer chain collapses since the reaction temperature is much beyond the VPTT and precipitates from solution to form a parent molecule which grows via aggregation with other phase-separated polymer chains to form microgels [97]. When polymerization is completed, the mixture is left to reach room temperature, the microgel system swells and attain a “furry” morphology. At temperature under the VPTT, microgels are sterically stabilized owing to the presence of hydrogen bonds between the polymer fragments and water molecules [86,96]. This method has been extensively employed for the preparation of thermosensitive PNIPAM [97,98,99,100,101,102,103,104,105,106,107,108,109,110,111] and poly(N-vinylcaprolactam) (PVCL) [102].
Karg et al. [104] employed the precipitation polymerization method to prepare gold nanorod-coated PNIPAM microgels. They studied the thermal behaviour of the microgels using an ultraviolet-visible spectrometer. The spectra were measured at 15–50 °C, where the microgels were fully swollen at 15 °C and totally deswollen at 50 °C which suggested the presence of two distinct nanorod loading systems, with low and high surface coverage. From the spectra, they observed a rise in absorbance at low wavelength up to 650 nm, and a red-shift and enhanced longitudinal plasmon band. These effects were correlated with the improved refractive index of the gel during compression of the microgel, which increased the Rayleigh scattering radiation [104,105] and also increased the local refractive index adjacent the Au nanorods [106,107]. In conclusion, their results also confirmed that the VPT of pure PNIPAM microgel is completely reversible.
Das and colleagues [106] also used the precipitation polymerization method to prepare a group of thermo-responsive microgels loaded with gold nanorods and they investigated their thermal-induced volume transitions to establish a framework with an intense transition in the physiologically appropriate range between 38–41 °C in saline buffer solution with a pH of 7.4. They picked the two most optimistic microgels, specifically poly(NIPAm-MA) microgels (series M2) and poly(NIPAm-NIPMAm)/PAA IPN microgels (series IPN4), to investigate the integration of the nanorods in the microgel core. TEM images of the two systems revealed that the nanorods were successfully incorporated and evenly dispersed within the microgels. Secondly, they studied thermal-induced transitions in the size of hybrid microgels and discovered that, at room temperature, series M2 had a smaller diameter (by about 7%), than the pure microgels, which was ascribed to the higher ionic strength of the hybrid material and cross-linking of the microgel moiety with the nanorods. When the temperature was raised, the hybrid microgel collapsed to smaller size. The VPTT took place in the speculated range of 38–41 °C and the VPTT of the hybrid system and the pure microgel was very similar. A similar trend was observed for hybrid poly(NIPAm-NIPAm)/PAA microgels but the degree of contraction of the hybrid microgel was considerably less than that of the pure microgel. They also investigated the photothermally induced VPT of the hybrid systems. The microgels were expose to radiation at λ = 809 nm and experienced great reversible, photothermally induced volume transition. These two microgels are potential candidates for photothermally regulated drug release.

4.3. Hybrid Metal Sulfide-Microgels

Extensive research has been conducted in the design of hybrid metal sulfide microgels. The combination of the microgel and metal sulfide materials may offer novel compounds with a vast array of advantages [73]. The use of naturally occurring and biocompatible polymers as templates for preparation of metal sulfide quantum dots (QDs) presents significant advantages compared to other techniques. Farooq et al. [109] used a gum Arabic (GA) microgel as template for the preparation of metal sulfide quantum dots (QDs). Metal ions were loaded into GA microgels and treated with aqueous sodium sulfide solution. Transmission electron microscopy (TEM) image revealed the metal sulfide QDs were successfully incorporated and evenly distributed within the microgel. Growth of properly shaped QDs crystals with the microgel matrix was observed. Pich et al. reported the preparation of hybrid microgels loaded with ZnS nanomaterials. The prepared hybrid microgels possessed both thermosensitive properties of the polymer (poly(N-vinylcaprolactam-co-acetoacetoxyethylmethacrylate) microgel and physical and chemical attributes of the ZnS material. Powder XRD results revealed low intense peaks for the hybrids which was correlated with the partial crystalline nature and low concentration of the ZnS nanomaterials within the microgel matrix.

4.4. Polymer Nanofibers

Nanofibers are fibers with a diameter of less than 100 nm. Nanofibers possess desirable properties that are convenient for biomedical, and biotechnology uses such as tissue engineering frameworks, drug delivery systems, biosensors, medical implants, etc. These properties include their large surface-to-volume ratio, tiny pore size, distinguished porosity, and unique physicochemical and biological properties [109,110]. In addition, nanofibers have large surface than the normal fibers since they have a one-dimensional (1D) structure [111].
Various natural biomaterials such as keratin, collagen, polysaccharide cellulose and chitin, are well ordered fibrous structures that exist at nanometer scale. This makes polymer nanofibers appropriate to provide a suitable method to mimic biosystems. Since cells live in a micro- or nano-featured environment, polymer nanofibers have an ability to regulate cellular actions with regards to cell adhesion, stimulation, proliferation, arrangement and orientation [110]. Polymer nanofibers can be used as drug delivery platforms since they have ability to allow controlled drug release. The dissolution rate of a drug and the surface area of the encapsulated drug have a direct relation [112].
Yang et al. [113] developed doxorubicin-encapsulated active-targeting micelles in poly(vinyl)alcohol/gelatin core-shell nanofibers for drug delivery. These electrospun nanofibers afforded a prominent therapeutic efficiency by means of minimum drug dosage, yet the systematic drug subjection to normal tissues was effectively diminished. Shao et al. [114] fabricated poly(ɛ-caprolactone)/multi-walled carbon nanotubes composite nanofibers loaded with green tea polyphenols (GTP). The nanofibers showed reduced cytotoxicity for healthy cells, however, inhibition effect to tumour cells was high which suggested that this material might be a good candidate for cancer treatment.

4.4.1. Fabrication of Nanofibers

Several fabrication methods such as electrospinning, template synthesis, drawing, phase separation and self-assembly have been employed to make appropriate polymer nanofibers for different purposes [109,115]. Although there are several routes used to prepare nanofibers, electrospinning remains the most popular technique for nanofiber preparation [110]. Electrospinning is a renowned procedure used to produce continuous, one-dimensional (1D) fibers with diameters varying between nanometers (nm) to micrometers (μm) [116,117]. During the process, a polymer solution gets spun at high voltage through electrostatic charging [117,118,119]. It is very cost effective, has high production rates and is straightforward. This technique offers homogenous and lengthy fibers with various morphologies such as a hollow, rigid and core-shell chemical frameworks [120]. These fibers exhibit incredibly high surface-to-volume ratios which makes them perfect carriers for the controlled delivery of pharmaceutical agents such as anticancer drugs, antibiotics, some vitamins and growth factors [110].

4.4.2. Formation of Nanofiber by Electrospinning

In the general process, a polymer solution (contained in a syringe pump) pushed through a syringe needle and a grounded target is subjected to an electric field. A spurt gets discharged from the surface of the charged polymer solution when the applied voltage and electrostatic repulsion counteracts the surface tension which results in the construction of a so-called Taylor cone [121]. When the voltage surpasses a certain limit, the electric force overpowers the surface tension of the droplet and then the charged spurts of the solution are expelled from the tip of the droplet depending on the intensity of the electric field. As the jet travels in the direction of a collecting counter electrode, the solvent evaporates and results in the formation of a fabric-like mat [122,123].
The morphology and diameter of electrospun nanofibers depend on several electrospinning parameters. (1) Solution conditions such as viscosity, conductivity surface tension and elasticity [124]. It was established that solution viscosity influences the diameter of the fiber [125], morphology [126] and the jet path [127]. Also, polymer solution with low viscosity result in electrospraying, meaning instead of getting fibers, small particles are produced [128]. Beachley et al. [129] discovered that the length, diameter and uniformity of polycaprolactone (PCL) nanofibers increases with increasing polymer viscosity. (2) Processing conditions such as applied voltage, needle diameter, tip-target length and feeding rate of the polymer solution [122,130,131]. (3) The environmental variables such as the temperature, humidity and static electricity. The humidity and temperature of the surrounds may influence the morphology and diameter of the fibers [132]. Casper et al. [133] investigated the impact of humidity and solution viscosity on the surface of electrospun polystyrene fibers. When the fibers were electrospun in an environment with a humidity below 25%, uniform fibers with no pores on the surface were obtained, but with a humidity greater than 30%, pores started forming on the surface of the fibers. Therefore, increasing humidity resulted in occurrence of thick and scattered pores on the fibers. In addtion, an increase in the molecular weight of the polystyrene yielded thicker and irregular shaped fibers with larger pores.
Kehren et al. [111] prepared homogenous poly(vinyl alcohol) (PVA) and poly(N-vinylcaprolactam) (PVCL) microgel microfibers using the electrospinning technique. They investigated the solution parameters to decide the best conditions to achieve fibers free of defects and defined morphology. Different PVA/microgel solutions were electrospun and discovered which shows that at lower PVA concentrations, no defined fibers were formed. Whereas with concentrated polymer solution, defined morphologies were obtained. They discovered that the polymer solution viscosity and flow rate play a vital role in the production of the fibers. The properties of the microgels were investigated by differential scanning calorimetry (DSC) and thermos-gravimetric analysis (TGA). DSC was used to evaluate the volume phase transition of the microgel-based fibers which proved that the microgel particles undergo reversible VPT. The swelling properties of the microgels and fibers were determined by TGA. The results revealed that the thermos-response of the microgels is sustained within the fibers. Toxicity evaluations revealed that the microgels and the fibers are non-toxic, which implied that they can be used for biomedical applications.

5. Conclusions

Semiconductor metal sulfide nanomaterials have been synthesized, characterized, and applied in various fields; however, very little information is available with regards to their medical applications. The approaches used for the preparation of metal sulfide nanomaterials as well as their use as drug delivery agents, diagnostic tools and probably therapeutic agents are of great interest. The main shortcoming of these materials lies in their poor water solubility; however, they possess some other fascinating properties such as size-dependency, more binding sites and photothermal properties which could enhance their application in the biomedical field. Stimuli-responsive microgels are promising drug delivery platforms. Their high-water solubility and biocompatibility make them good templates for the design of hybrid microgels which can be loaded with metal sulfide nanomaterials for drug delivery purposes. Since metal sulfide nanomaterials have poor solubility, encapsulating them within a microgel matrix might be a solution. This could lead to the development of potent therapeutic agents in the future.

Author Contributions

A.M.P. writing—draft preparation and corrections. P.A.A. Supervision, funding acquisition, writing—review, and final editing. All authors have read and agreed to the published version of the manuscript.

Funding

The National Research Foundation is acknowledge for funding.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Boisseau, P.; Loubaton, B. Nanomedicine, nanotechnology in medicine. Comptes Rendus Physique 2011, 12, 620–636. [Google Scholar] [CrossRef] [Green Version]
  2. Khan, I.; Saeed, K.; Khan, I. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019, 12, 908–931. [Google Scholar] [CrossRef]
  3. Gajanan, K.; Tijare, S. Applications of nanomaterials. Mater. Today Proc. 2018, 5, 1093–1096. [Google Scholar] [CrossRef]
  4. Pan, Y.; Bartneck, M.; Jahnen-Dechent, W. Cytotoxicity of gold nanoparticles. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 2012; Volume 509, pp. 225–242. [Google Scholar]
  5. Nayak, M.K.; Singh, J.; Singh, B.; Soni, S.; Pandey, V.S.; Tyagi, S. Metal Semiconductor Core-Shell Nanostructures for Energy and Environmental Applications; Elsevier: Amsterdam, The Netherlands, 2017; pp. 1–33. [Google Scholar]
  6. Bhatia, S. Natural Polymer Drug Delivery Systems; Springer: New York, NY, USA, 2016; pp. 1–33. [Google Scholar]
  7. Cartaxo, A.L.P. Nanoparticles types and properties–understanding these promising devices in the biomedical area. Int. J. Nanomed. 2018, 1–8. [Google Scholar]
  8. Reghunadhan, A.; Kalarikkal, N.; Thomas, S. Characterization of Nanomaterials; Elsevier: Amsterdam, The Netherlands, 2018; pp. 191–212. [Google Scholar]
  9. Gaiardo, A.; Fabbri, B.; Guidi, V.; Bellutti, P.; Giberti, A.; Gherardi, S.; Vanzetti, L.; Malagù, C.; Zonta, G. Metal sulfides as sensing materials for chemoresistive gas sensors. Sensors 2016, 16, 296. [Google Scholar] [CrossRef] [PubMed]
  10. Bobo, D.; Robinson, K.J.; Islam, J.; Thurecht, K.J.; Corrie, S.R. Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date. Pharm. Res. 2016, 33, 2373–2387. [Google Scholar] [CrossRef] [PubMed]
  11. Rao, C.; Pisharody, K. Transition metal sulfides. Prog. Solid State Chem. 1976, 10, 207–270. [Google Scholar] [CrossRef]
  12. Gross, S.; Vittadini, A.; Dengo, N. Functionalisation of Colloidal Transition Metal Sulphides Nanocrystals: A Fascinating and Challenging Playground for the Chemist. Crystals 2017, 7, 110. [Google Scholar] [CrossRef] [Green Version]
  13. Lai, C.-H.; Lu, M.-Y.; Chen, L.-J. Metal sulfide nanostructures: Synthesis, properties and applications in energy conversion and storage. J. Mater. Chem. 2012, 22, 19–30. [Google Scholar] [CrossRef]
  14. Owens, G.J.; Singh, R.K.; Foroutan, F.; Alqaysi, M.; Han, C.-M.; Mahapatra, C.; Kim, H.-W.; Knowles, J.C. Sol-gel based materials for biomedical applications. Prog. Mater. Sci. 2016, 77, 1–79. [Google Scholar] [CrossRef] [Green Version]
  15. Lue, J.T. Physical properties of nanomaterials. Encycl. Nanosci. Nanotechnol. 2007, 10, 1–46. [Google Scholar]
  16. Khan, M.F.; Ansari, A.H.; Hameedullah, M.; Ahmad, E.; Husain, F.M.; Zia, Q.; Baig, U.; Zaheer, M.R.; Alam, M.M.; Khan, A.M. Sol-gel synthesis of thorn-like ZnO nanoparticles endorsing mechanical stirring effect and their antimicrobial activities: Potential role as nano-antibiotics. Sci. Rep. 2016, 6, 1–12. [Google Scholar] [CrossRef]
  17. Pudukudy, M.; Yaakob, Z.; Mazuki, M.Z.; Takriff, M.S.; Jahaya, S.S. One-pot sol-gel synthesis of MgO nanoparticles supported nickel and iron catalysts for undiluted methane decomposition into COx free hydrogen and nanocarbon. Appl. Catal. B 2017, 218, 298–316. [Google Scholar] [CrossRef]
  18. Thilagavathi, P.; Manikandan, A.; Sujatha, S.; Jaganathan, S.K.; Arul Antony, S. Sol-gel synthesis and characterization studies of NiMoO4 nanostructures for photocatalytic degradation of methylene blue dye. Nanosci. Nanotechnol. Lett. 2016, 8, 438–443. [Google Scholar] [CrossRef]
  19. Zorkipli, N.N.M.; Kaus, N.H.M.; Mohamad, A.A. Synthesis of NiO nanoparticles through sol-gel method. Procedia Chem. 2016, 19, 626–631. [Google Scholar] [CrossRef] [Green Version]
  20. Li, J.; Wu, Q.; Wu, J. Synthesis of Nanoparticles via Solvothermal and Hydrothermal Methods. In Handbook of Nanoparticles; Springer International Publishing: Cham, Switzerland, 2015; pp. 1–28. [Google Scholar]
  21. Camargo, P.H.C.; Satyanarayana, K.G.; Wypych, F. Nanocomposites: Synthesis, structure, properties and new application opportunities. Mat. Res. 2009, 12, 1–39. [Google Scholar] [CrossRef] [Green Version]
  22. Ajibade, P.A.; Botha, N.L. Synthesis and structural studies of copper sulfide nanocrystals. Res. Phys. 2016, 6, 581–589. [Google Scholar] [CrossRef] [Green Version]
  23. Paca, A.M.; Ajibade, P.A. Synthesis and structural studies of iron sulphide nanocomposites prepared from Fe(III) dithiocarbamates single source precursors. Mater. Chem. Phys. 2017, 202, 143–150. [Google Scholar] [CrossRef]
  24. Ajibade, P.A.; Oluwalana, A.E.; Andrew, F.P. Morphological studies, photocatalytic activity, and electrochemistry of platinum disulfide nanoparticles from bis(morpholinyl-4-carbodithioato)-platinum(II). ACS Omega 2020, 5, 27142–27153. [Google Scholar] [CrossRef]
  25. Paca, A.M.; Ajibade, P.A. Bis-(N-ethylphenyldithiocarbamato) palladium(II) as molecular precursor for palladium sulfide nanoparticles. J. Mol. Struct. 2021, 1243, 130777. [Google Scholar] [CrossRef]
  26. Paca, A.M.; Ajibade, P.A. Effect of temperature on structural and optical properties of iron sulfide nanocrystals prepared from tris(N-methylbenzyldithiocarbamato)iron(III) complex. Inorg. Nano-Met. Chem. 2021, 51, 322–331. [Google Scholar] [CrossRef]
  27. Angeloski, A.; Gentle, A.R.; Scott, J.A.; Cortie, M.B.; Hook, J.M.; Westerhausen, M.T.; Bhadbhade, M.; Baker, A.T.; McDonagh, A.M. From lead(II) dithiocarbamate precursors to a fast response PbS positive temperature coefficient thermistor. Inorg. Chem. 2018, 57, 2132–2140. [Google Scholar] [CrossRef] [PubMed]
  28. Ajibade, P.A.; Oluwalana, A.E.; Sikakane, B.M.; Singh, M. Structural, photocatalytic and anticancer studies of hexadecylamine capped ZnS nanoparticles. Chem. Phys. Lett. 2020, 755, 137813. [Google Scholar] [CrossRef]
  29. Boncher, W.L.; Regulacio, M.D.; Stoll, S.L. Thermolysis of lanthanide dithiocarbamate complexes. J. Solid State Chem. 2010, 183, 52–56. [Google Scholar] [CrossRef]
  30. Pradhan, N.; Efrima, S. Single-precursor, one-pot versatile synthesis under near ambient conditions of tunable, single and dual band fluorescing metal sulfide nanoparticles. J. Am. Chem. Soc. 2003, 125, 2050–2051. [Google Scholar] [CrossRef]
  31. Khan, A.; Hayat, F.; Butler, I.S.; Tahir, M.N. Mercury(II) dithiocarbamates: Structural aspects and their use as single source precursors for shape-controlled facile synthesis of HgS nanoparticles. Polyhedron 2020, 193, 1–33. [Google Scholar] [CrossRef]
  32. Arandhara, G.; Mostako, A.; Dutta, P.; Bora, J.; Saikia, P. Influence of thermolysis temperature on the morphology, structural and optical properties of nanocomposite ZnS-polyvinyl alcohol thin films: Fabrication and characterization of indium tin oxide/ZnS-polyvinyl alcohol/Al Schottky diode. Thin Solid Films 2020, 712, 138317. [Google Scholar] [CrossRef]
  33. Ul Ain, N.; Aamir, A.; Khan, Y.; Rehman, M.-u.; Lin, D.-J. Catalytic and photocatalytic efficacy of hexagonal CuS nanoplates derived from copper(II) dithiocarbamate. Mater. Chem. Phys. 2020, 242, 122408. [Google Scholar] [CrossRef]
  34. Cho, K.; Wang, X.; Nie, S.; Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 2008, 14, 1310–1316. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Wong, I.Y.; Bhatia, S.N.; Toner, M. Nanotechnology: Emerging tools for biology and medicine. Genes Dev. 2013, 27, 2397–2408. [Google Scholar] [CrossRef] [Green Version]
  36. Banik, B.L.; Brown, J.L. Natural and Synthetic Biomedical Polymers; Elsevier: Amsterdam, The Netherlands, 2014; pp. 387–395. [Google Scholar]
  37. Argueta-Figueroa, L.; Martinez-Alvarez, O.; Santos-Cruz, J.; Garcia-Contreras, R.; Acosta-Torres, L.; De la Fuente-Hernandez, J.; Arenas-Arrocena, M. Nanomaterials made of non-toxic metallic sulfides: A systematic review of their potential biomedical applications. Mater. Sci. Eng. C 2017, 76, 1305–1315. [Google Scholar] [CrossRef] [PubMed]
  38. Kolahalam, L.A.; Viswanath, I.K.; Diwakar, B.S.; Govindh, B.; Reddy, V.; Murthy, Y. Review on nanomaterials: Synthesis and applications. Mater. Today 2019, 18, 2182–2190. [Google Scholar] [CrossRef]
  39. Li, C.; Wang, Y.; Jiang, H.; Wang, X. Biosensors Based on Advanced Sulfur-Containing Nanomaterials. Sensors 2020, 20, 3488. [Google Scholar] [CrossRef]
  40. Zhou, H.; Ge, J.; Miao, Q.; Zhu, R.; Wen, L.; Zeng, J.; Gao, M. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior. Bioconjugate Chem. 2019, 31, 315–331. [Google Scholar] [CrossRef] [PubMed]
  41. Chen, K.; Wang, C.; Peng, Z.; Qi, K.; Guo, Z.; Zhang, Y.; Zhang, H. The chemistry of colloidal semiconductor nanocrystals: From metal-chalcogenides to emerging perovskite. Coord. Chem. Rev. 2020, 418, 1–20. [Google Scholar] [CrossRef]
  42. Yang, W.; Guo, W.; Chang, J.; Zhang, B. Protein/peptide-templated biomimetic synthesis of inorganic nanoparticles for biomedical applications. J. Mater. Chem. B 2017, 5, 401–417. [Google Scholar] [CrossRef] [PubMed]
  43. Yan, H.; Chen, J.; Li, Y.; Bai, Y.; Wu, Y.; Sheng, Z.; Song, L.; Liu, C.; Zhang, H. Ultrasmall hybrid protein–copper sulfide nanoparticles for targeted photoacoustic imaging of orthotopic hepatocellular carcinoma with a high signal-to-noise ratio. Biomater. Sci. 2019, 7, 92–103. [Google Scholar] [CrossRef] [PubMed]
  44. Yang, D.; Chen, F.; He, S.; Shen, H.; Hu, Y.; Feng, N.; Wang, S.; Weng, L.; Luo, Z.; Wang, L. One-pot growth of triangular SnS nanopyramids for photoacoustic imaging and photothermal ablation of tumors. New J. Chem. 2019, 43, 13256–13262. [Google Scholar] [CrossRef]
  45. Wang, Y.; Wu, Y.; Liu, Y.; Shen, J.; Lv, L.; Li, L.; Yang, L.; Zeng, J.; Wang, Y.; Zhang, L.W. BSA-mediated synthesis of bismuth sulfide nanotheranostic agents for tumor multimodal imaging and thermoradiotherapy. Adv. Funct. Mater. 2016, 26, 5335–5344. [Google Scholar] [CrossRef]
  46. Lin, S.; Wang, Y.; Chen, Z.; Li, L.; Zeng, J.; Dong, Q.; Wang, Y.; Chai, Z. Biomineralized enzyme-like cobalt sulfide nanodots for synergetic phototherapy with tumor multimodal imaging navigation. ACS Sustain. Chem. Eng. 2018, 6, 12061–12069. [Google Scholar] [CrossRef]
  47. Li, Y.; Lu, W.; Huang, Q.; Li, C.; Chen, W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 2010, 5, 1161–1171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Fan, J.-X.; Liu, M.-D.; Li, C.-X.; Hong, S.; Zheng, D.-W.; Liu, X.-H.; Chen, S.; Cheng, H.; Zhang, X.-Z. A metal–semiconductor nanocomposite as an efficient oxygen-independent photosensitizer for photodynamic tumor therapy. Nanoscale Horiz. 2017, 2, 349–355. [Google Scholar] [CrossRef] [PubMed]
  49. Yu, H.; Yang, Y.; Jiang, T.; Zhang, X.; Zhao, Y.; Pang, G.; Feng, Y.; Zhang, S.; Wang, F.; Wang, Y. Effective Radiotherapy in Tumor Assisted by Ganoderma lucidum Polysaccharide-Conjugated Bismuth Sulfide Nanoparticles through Radiosensitization and Dendritic Cell Activation. ACS Appl. Mater. Inter. 2019, 11, 27536–27547. [Google Scholar] [CrossRef] [PubMed]
  50. Wang, D.; Dong, H.; Li, M.; Cao, Y.; Yang, F.; Zhang, K.; Dai, W.; Wang, C.; Zhang, X. Erythrocyte–cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano 2018, 12, 5241–5252. [Google Scholar] [CrossRef]
  51. Sakthivel, R.; Kubendhiran, S.; Chen, S.-M.; Chen, T.-W.; Al-Zaqri, N.; Alsalme, A.; Alharthi, F.A.; Khanjer, M.M.A.; Tseng, T.-W.; Huang, C.-C. Exploring the promising potential of MoS2–RuS2 binary metal sulphide towards the electrocatalysis of antibiotic drug sulphadiazine. Anal. Chim. Acta 2019, 1086, 55–65. [Google Scholar] [CrossRef] [PubMed]
  52. Sangili, A.; Sakthivel, R.; Chen, S.M. Cost-effective single-step synthesis of flower-like cerium-ruthenium-sulfide for the determination of antipsychotic drug trifluoperazine in human urine samples. Anal. Chim. Acta 2020, 1131, 35–44. [Google Scholar] [CrossRef] [PubMed]
  53. Lu, Z.; Huang, F.-y.; Cao, R.; Zhang, L.; Tan, G.-h.; He, N.; Huang, J.; Wang, G.; Zhang, Z. Long blood residence and large tumor uptake of ruthenium sulfide nanoclusters for highly efficient cancer photothermal therapy. Sci. Rep. 2017, 7, 1–9. [Google Scholar] [CrossRef] [Green Version]
  54. Xie, Z.; Wang, D.; Fan, T.; Xing, C.; Li, Z.; Tao, W.; Liu, L.; Bao, S.; Fan, D.; Zhang, H. Black phosphorus analogue tin sulfide nanosheets: Synthesis and application as near-infrared photothermal agents and drug delivery platforms for cancer therapy. J. Mater. Chem. B 2018, 6, 4747–4755. [Google Scholar] [CrossRef]
  55. Han, L.; Hao, Y.-N.; Wei, X.; Chen, X.-W.; Shu, Y.; Wang, J.-H. Hollow copper sulfide nanosphere–doxorubicin/graphene oxide core–shell nanocomposite for photothermo-chemotherapy. ACS Biomater. Sci. Eng. 2017, 3, 3230–3235. [Google Scholar] [CrossRef] [PubMed]
  56. Hou, L.; Shan, X.; Hao, L.; Feng, Q.; Zhang, Z. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform. Acta Biomater. 2017, 54, 307–320. [Google Scholar] [CrossRef] [PubMed]
  57. Lavik, E.B.; Kuppermann, B.D.; Humayun, M.S. Retina, 5th ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2012. [Google Scholar]
  58. Wu, W.; Zhou, T.; Berliner, A.; Banerjee, P.; Zhou, S. Smart core−shell hybrid nanogels with Ag nanoparticle core for cancer cell imaging and gel shell for pH-regulated drug delivery. Chem. Mater. 2010, 22, 1966–1976. [Google Scholar] [CrossRef]
  59. Kheirandish, S.; Ghaedi, M.; Dashtian, K.; Pourebrahim, F.; Jannesar, R.; Pezeshkpour, V. In vitro curcumin delivery and antibacterial activity of RuS2 and RuO2 nanoparticles loaded chitosan biopolymer. Appl. Organomet. Chem. 2018, 32, e4035. [Google Scholar] [CrossRef]
  60. Torchilin, V.P. Stimuli-Responsive Drug Delivery Systems; Royal Society of Chemistry: London, UK, 2018. [Google Scholar]
  61. Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751. [Google Scholar] [CrossRef] [PubMed]
  62. Torchilin, V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 2006, 58, 1532–1555. [Google Scholar] [CrossRef] [PubMed]
  63. Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3, 16–20. [Google Scholar] [CrossRef]
  64. Owens, D.E., III; Peppas, N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. Sci. Res. 2006, 307, 93–102. [Google Scholar] [CrossRef]
  65. De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 2008, 3, 133–149. [Google Scholar] [CrossRef] [Green Version]
  66. Zhuang, J.; Gordon, M.R.; Ventura, J.; Li, L.; Thayumanavan, S. Multi-stimuli responsive macromolecules and their assemblies. Chem. Soc. Rev. 2013, 42, 7421–7435. [Google Scholar] [CrossRef] [PubMed]
  67. Abulateefeh, S.R.; Spain, S.G.; Aylott, J.W.; Chan, W.C.; Garnett, M.C.; Alexander, C. Thermoresponsive polymer colloids for drug delivery and cancer therapy. Macromol. Biosci. 2011, 11, 1722–1734. [Google Scholar] [CrossRef] [PubMed]
  68. Zhu, L.; Torchilin, V.P. Stimulus-responsive nanopreparations for tumor targeting. Integr. Biol. 2013, 5, 96–107. [Google Scholar] [CrossRef] [PubMed]
  69. Agrawal, G.; Agrawal, R. Stimuli-Responsive Microgels and Microgel-Based Systems: Advances in the Exploitation of Microgel Colloidal Properties and Their Interfacial Activity. Polymers 2018, 10, 418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Smeets, N.M.; Hoare, T. Designing responsive microgels for drug delivery applications. J. Polym. Sci. Part A Polym. Chem. 2013, 51, 3027–3043. [Google Scholar] [CrossRef]
  71. Vinogradov, S.V. Colloidal microgels in drug delivery applications. Curr. Pharm. Des. 2006, 12, 4703–4712. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Oh, J.K.; Drumright, R.; Siegwart, D.J.; Matyjaszewski, K. The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 2008, 33, 448–477. [Google Scholar] [CrossRef]
  73. Bai, C.; Fang, Y.; Zhang, Y.; Chen, B. Synthesis of novel metal sulfide−polymer composite microspheres exhibiting patterned surface structures. Langmuir 2004, 20, 263–265. [Google Scholar] [CrossRef]
  74. Thomas, V.; Namdeo, M.; Murali Mohan, Y.; Bajpai, S.; Bajpai, M. Review on polymer, hydrogel and microgel metal nanocomposites: A facile nanotechnological approach. J. Macromol. Sci. Part A Pure Appl. Chem. 2007, 45, 107–119. [Google Scholar] [CrossRef]
  75. Nachev, P.; Van’t Zand, D.D.; Coger, V.; Wagener, P.; Reimers, K.; Vogt, P.M.; Barcikowski, S.; Pich, A. Synthesis of hybrid microgels by coupling of laser ablation and polymerization in aqueous medium. J. Laser Appl. 2012, 24, 1–7. [Google Scholar] [CrossRef]
  76. Zhang, J.; Xu, S.; Kumacheva, E. Polymer microgels: Reactors for semiconductor, metal, and magnetic nanoparticles. J. Am. Chem. Soc. 2004, 126, 7908–7914. [Google Scholar] [CrossRef] [PubMed]
  77. Gong, Y.; Gao, M.; Wang, D.; Möhwald, H. Incorporating fluorescent CdTe nanocrystals into a hydrogel via hydrogen bonding: Toward fluorescent microspheres with temperature-responsive properties. Chem. Mater. 2005, 17, 2648–2653. [Google Scholar] [CrossRef]
  78. Pich, A.; Zhang, F.; Shen, L.; Berger, S.; Ornatsky, O.; Baranov, V.; Winnik, M.A. Biocompatible hybrid nanogels. Small 2008, 4, 2171–2175. [Google Scholar] [CrossRef]
  79. Lutz, J.F. Thermo-switchable materials prepared using the OEGMA-platform. Adv. Mater. 2011, 23, 2237–2243. [Google Scholar] [CrossRef]
  80. Ramos, J.; Imaz, A.; Forcada, J. Temperature-sensitive nanogels: Poly(N-vinylcaprolactam) versus poly(N-isopropylacrylamide). Polym. Chem. 2012, 3, 852–856. [Google Scholar] [CrossRef]
  81. Bebis, K.; Jones, M.W.; Haddleton, D.M.; Gibson, M.I. Thermoresponsive behaviour of poly((oligo (ethyleneglycol methacrylate)) s and their protein conjugates: Importance of concentration and solvent system. Polym. Chem. 2011, 2, 975–982. [Google Scholar] [CrossRef]
  82. Lima, L.H.; Morales, Y.; Cabral, T. Ocular Biocompatibility of Poly-N-Isopropylacrylamide (pNIPAM). J. Ophthalmol. 2016, 2016. [Google Scholar] [CrossRef] [Green Version]
  83. Haq, M.A.; Su, Y.; Wang, D. Mechanical properties of PNIPAM based hydrogels: A review. Mater. Sci. Eng. C 2017, 70, 842–855. [Google Scholar] [CrossRef] [PubMed]
  84. Daly, E.; Saunders, B.R. A study of the effect of electrolyte on the swelling and stability of poly(N-isopropylacrylamide) microgel dispersions. Langmuir 2000, 16, 5546–5552. [Google Scholar] [CrossRef]
  85. Singh, R.; Deshmukh, S.A.; Kamath, G.; Sankaranarayanan, S.K.; Balasubramanian, G. Controlling the aqueous solubility of PNIPAM with hydrophobic molecular units. Comp. Mater. Sci. 2017, 126, 191–203. [Google Scholar] [CrossRef] [Green Version]
  86. Pelton, R. Temperature-sensitive aqueous microgels. Adv. Colloid Interface Sci. 2000, 85, 1–33. [Google Scholar] [CrossRef]
  87. Jung, J.; Lee, I.-H.; Lee, E.; Park, J.; Jon, S. pH-sensitive polymer nanospheres for use as a potential drug delivery vehicle. Biomacromolecules 2007, 8, 3401–3407. [Google Scholar] [CrossRef] [PubMed]
  88. Shi, L.; Khondee, S.; Linz, T.H.; Berkland, C. Poly(N-vinylformamide) nanogels capable of pH-sensitive protein release. Macromolecules 2008, 41, 6546–6554. [Google Scholar] [CrossRef]
  89. Hu, Y.; Atukorale, P.U.; Lu, J.J.; Moon, J.J.; Um, S.H.; Cho, E.C.; Wang, Y.; Chen, J.; Irvine, D.J. Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core−shell gel particles. Biomacromolecules 2009, 10, 756–765. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Stubbs, M.; McSheehy, P.M.; Griffiths, J.R.; Bashford, C.L. Causes and consequences of tumour acidity and implications for treatment. Mol. Med. Today 2000, 6, 15–19. [Google Scholar] [CrossRef]
  91. Torchilin, V.P. Micellar nanocarriers: Pharmaceutical perspectives. Pharm. Res. 2007, 24, 1. [Google Scholar] [CrossRef] [PubMed]
  92. Coakley, R.D.; Grubb, B.R.; Paradiso, A.M.; Gatzy, J.T.; Johnson, L.G.; Kreda, S.M.; O’Neal, W.K.; Boucher, R.C. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc. Natl. Acad. Sci. USA 2003, 100, 16083–16088. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Muratalin, M.; Luckham, P.F.; Esimova, A.; Aidarova, S.; Mutaliyeva, B.; Madybekova, G.; Sharipova, A.; Issayeva, A. Study of N-isopropylacrylamide-based microgel particles as a potential drug delivery agents. Colloids Surf. A 2017, 532, 8–17. [Google Scholar] [CrossRef]
  94. Khan, J.; Siddiq, M.; Akram, B.; Ashraf, M.A. In-situ synthesis of CuO nanoparticles in P (NIPAM-co-AAA) microgel, structural characterization, catalytic and biological applications. Arab. J. Chem. 2018, 11, 897–909. [Google Scholar] [CrossRef]
  95. Farooqi, Z.H.; Khan, S.R.; Begum, R.; Ijaz, A. Review on synthesis, properties, characterization, and applications of responsive microgels fabricated with gold nanostructures. Rev. Chem. Eng. 2016, 32, 49–69. [Google Scholar] [CrossRef]
  96. Pich, A.; Richtering, W. Chemical Design of Responsive Microgels; Springer: New York, NY, USA, 2010; pp. 1–37. [Google Scholar]
  97. Duracher, D.; Elaïssari, A.; Pichot, C. Preparation of poly(N-isopropylmethacrylamide) latexes kinetic studies and characterization. J. Polym. Sci. Part A Polym. Chem. 1999, 37, 1823–1837. [Google Scholar] [CrossRef]
  98. Huang, G.; Gao, J.; Hu, Z.; John, J.V.S.; Ponder, B.C.; Moro, D. Controlled drug release from hydrogel nanoparticle networks. J. Control. Release 2004, 94, 303–311. [Google Scholar] [CrossRef] [PubMed]
  99. Hoare, T.; Pelton, R. Functional group distributions in carboxylic acid containing poly(N-isopropylacrylamide) microgels. Langmuir 2004, 20, 2123–2133. [Google Scholar] [CrossRef] [PubMed]
  100. Leobandung, W.; Ichikawa, H.; Fukumori, Y.; Peppas, N.A. Monodisperse nanoparticles of poly (ethylene glycol) macromers and N-isopropyl acrylamide for biomedical applications. J. Appl. Polym. Sci. 2003, 87, 1678–1684. [Google Scholar] [CrossRef]
  101. Berndt, I.; Pedersen, J.S.; Lindner, P.; Richtering, W. Influence of Shell Thickness and Cross-Link Density on the Structure of Temperature-Sensitive Poly-N-Isopropylacrylamide−Poly-N-Isopropylmethacrylamide Core−Shell Microgels Investigated by Small-Angle Neutron Scattering. Langmuir 2006, 22, 459–468. [Google Scholar] [CrossRef] [PubMed]
  102. Boyko, V.; Pich, A.; Lu, Y.; Richter, S.; Arndt, K.-F.; Adler, H.-J.P. Thermo-sensitive poly(N-vinylcaprolactam-co-acetoacetoxyethyl methacrylate) microgels: 1—Synthesis and characterization. Polymer 2003, 44, 7821–7827. [Google Scholar] [CrossRef]
  103. Karg, M.; Pastoriza-Santos, I.; Pérez-Juste, J.; Hellweg, T.; Liz-Marzán, L.M. Nanorod-coated PNIPAM microgels: Thermoresponsive optical properties. Small 2007, 3, 1222–1229. [Google Scholar] [CrossRef]
  104. Kratz, K.; Hellweg, T.; Eimer, W. Structural changes in PNIPAM microgel particles as seen by SANS, DLS, and EM techniques. Polymer 2001, 42, 6631–6639. [Google Scholar] [CrossRef]
  105. Kratz, K.; Hellweg, T.; Eimer, W. Effect of connectivity and charge density on the swelling and local structural and dynamic properties of colloidal PNIPAM microgels. Ber. Bunsen Ges. Phys. Chem. 1998, 102, 1603–1608. [Google Scholar] [CrossRef]
  106. Das, M.; Sanson, N.; Fava, D.; Kumacheva, E. Microgels loaded with gold nanorods: Photothermally triggered volume transitions under physiological conditions. Langmuir 2007, 23, 196–201. [Google Scholar] [CrossRef]
  107. Gorelikov, I.; Field, L.M.; Kumacheva, E. Hybrid microgels photoresponsive in the near-infrared spectral range. J. Am. Chem. Soc. 2004, 126, 15938–15939. [Google Scholar] [CrossRef]
  108. Farooq, M.; Sagbas, S.; Yildiz, M.; Meral, K.; Siddiq, M.; Aktas, N.; Sahiner, N. Gum arabic microgels as template for in situ metal-sulfide based quantum dots preparation and their thermal, spectroscopic, optical, and magnetic characterization. J. Electron. Mater. 2017, 46, 4373–4383. [Google Scholar] [CrossRef]
  109. Sayed, A.; Asran, A.S. Electrospinning of Polymeric Nanofibers and Nanocomposite Materials: Fabrication, Physicochemical Characterization and Medical Applications. Ph.D. Thesis, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany, 9 February 2011. [Google Scholar]
  110. Huang, Z.-M.; Zhang, Y.-Z.; Kotaki, M.; Ramakrishna, S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos. Sci. Technol. 2003, 63, 2223–2253. [Google Scholar] [CrossRef]
  111. Kehren, D.; Pich, A. Fabrication and Characterisation of Microgel/Polymer Composite Microfibres. Macromol. Mater. Eng. 2013, 298, 1282–1293. [Google Scholar] [CrossRef]
  112. Koushik, O.; Rao, Y.; Kumar, P.; Karthikeyan, R. Nano Drug Delivery Systems to Overcome Cancer Drug Resistance-A Review. J. Nanomed. Nanotechnol. 2016, 7, 2. [Google Scholar]
  113. Yang, G.; Wang, J.; Wang, Y.; Li, L.; Guo, X.; Zhou, S. An implantable active-targeting micelle-in-nanofiber device for efficient and safe cancer therapy. ACS Nano 2015, 9, 1161–1174. [Google Scholar] [CrossRef] [PubMed]
  114. Shao, S.; Li, L.; Yang, G.; Li, J.; Luo, C.; Gong, T.; Zhou, S. Controlled green tea polyphenols release from electrospun PCL/MWCNTs composite nanofibers. Int. J. Pharm. Sci. Res. 2011, 421, 310–320. [Google Scholar] [CrossRef] [PubMed]
  115. Zhang, Y.; Lim, C.T.; Ramakrishna, S.; Huang, Z.-M. Recent development of polymer nanofibers for biomedical and biotechnological applications. J. Mater. Sci. Mater. Med. 2005, 16, 933–946. [Google Scholar] [CrossRef] [PubMed]
  116. Xue, J.; Wu, T.; Dai, Y.; Xia, Y. Electrospinning and electrospun nanofibers: Methods, materials, and applications. Chem. Rev. 2019, 119, 5298–5415. [Google Scholar] [CrossRef] [PubMed]
  117. Islam, M.S.; Ang, B.C.; Andriyana, A.; Afifi, A.M. A review on fabrication of nanofibers via electrospinning and their applications. SN Appl. Sci. 2019, 1, 1–16. [Google Scholar] [CrossRef] [Green Version]
  118. Miyauchi, M.; Simmons, T.J.; Miao, J.; Gagner, J.E.; Shriver, Z.H.; Aich, U.; Dordick, J.S.; Linhardt, R.J. Electrospun polyvinylpyrrolidone fibers with high concentrations of ferromagnetic and superparamagnetic nanoparticles. ACS Appl. Mater. Interfaces 2011, 3, 1958–1964. [Google Scholar] [CrossRef]
  119. Mariello, M.; Qualtieri, A.; Mele, G.; De Vittorio, M. Metal-Free Multilayer Hybrid PENG Based on Soft Electrospun/-Sprayed Membranes with Cardanol Additive for Harvesting Energy from Surgical Face Masks. ACS Appl. Mater. Interfaces 2021, 13, 20606–20621. [Google Scholar] [CrossRef] [PubMed]
  120. Reneker, D.H.; Chun, I. Nanometre diameter fibres of polymer, produced by electrospinning. Nanotechnology 1996, 7, 216. [Google Scholar] [CrossRef] [Green Version]
  121. Jalili, R.; Hosseini, S.A.; Morshed, M. The effects of operating parameters on the morphology of electrospun polyacrilonitrile nanofibres. Iran. Polym. J. 2005, 14, 1074–1081. [Google Scholar]
  122. Gupta, P.; Asmatulu, R.; Claus, R.; Wilkes, G. Superparamagnetic flexible substrates based on submicron electrospun Estane® fibers containing MnZnFe—Ni nanoparticles. J. Appl. Polym. Sci. 2006, 100, 4935–4942. [Google Scholar] [CrossRef]
  123. Hu, X.; Liu, S.; Zhou, G.; Huang, Y.; Xie, Z.; Jing, X. Electrospinning of polymeric nanofibers for drug delivery applications. J. Control. Release 2014, 185, 12–21. [Google Scholar] [CrossRef]
  124. Deitzel, J.M.; Kleinmeyer, J.; Harris, D.; Tan, N.B. The effect of processing variables on the morphology of electrospun nanofibers and textiles. Polymer 2001, 42, 261–272. [Google Scholar] [CrossRef]
  125. Jin, H.-J.; Fridrikh, S.V.; Rutledge, G.C.; Kaplan, D.L. Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules 2002, 3, 1233–1239. [Google Scholar] [CrossRef]
  126. Huang, C.; Chen, S.; Lai, C.; Reneker, D.H.; Qiu, H.; Ye, Y.; Hou, H. Electrospun polymer nanofibres with small diameters. Nanotechnology 2006, 17, 1558–1563. [Google Scholar] [CrossRef] [PubMed]
  127. Yarin, A.L.; Koombhongse, S.; Reneker, D.H. Taylor cone and jetting from liquid droplets in electrospinning of nanofibers. J. Appl. Phys. 2001, 90, 4836–4846. [Google Scholar] [CrossRef] [Green Version]
  128. Cheng, J.; Jun, Y.; Qin, J.; Lee, S.-H. Electrospinning versus microfluidic spinning of functional fibers for biomedical applications. Biomaterials 2017, 114, 121–143. [Google Scholar] [CrossRef] [PubMed]
  129. Beachley, V.; Wen, X. Effect of electrospinning parameters on the nanofiber diameter and length. Mater. Sci. Eng. C 2009, 29, 663–668. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  130. Zhang, C.; Yuan, X.; Wu, L.; Han, Y.; Sheng, J. Study on morphology of electrospun poly(vinyl alcohol) mats. Eur. Polym. J. 2005, 41, 423–432. [Google Scholar] [CrossRef]
  131. Son, W.K.; Youk, J.H.; Lee, T.S.; Park, W.H. Electrospinning of ultrafine cellulose acetate fibers: Studies of a new solvent system and deacetylation of ultrafine cellulose acetate fibers. J. Polym. Sci. Part B Polym. Phys. 2004, 42, 5–11. [Google Scholar] [CrossRef]
  132. Li, D.; Xia, Y. Electrospinning of nanofibers: Reinventing the wheel? Adv. Mater. 2004, 16, 1151–1170. [Google Scholar] [CrossRef]
  133. Casper, C.L.; Stephens, J.S.; Tassi, N.G.; Chase, D.B.; Rabolt, J.F. Controlling surface morphology of electrospun polystyrene fibers: Effect of humidity and molecular weight in the electrospinning process. Macromolecules 2004, 37, 573–578. [Google Scholar] [CrossRef]
Ijms 22 12294 sch001 550
Scheme 1. Schematic diagram of the thermolysis process.
Scheme 1. Schematic diagram of the thermolysis process.
Ijms 22 12294 sch001
Ijms 22 12294 g001 550
Figure 1. Comparison of nanoparticles and biological units.
Figure 1. Comparison of nanoparticles and biological units.
Ijms 22 12294 g001
Ijms 22 12294 g002 550
Figure 2. Application of the nanomaterials in the biomedical field.
Figure 2. Application of the nanomaterials in the biomedical field.
Ijms 22 12294 g002
Ijms 22 12294 g003 550
Figure 3. Tris(diethyldithiocarbamato)ruthenium(III) ([Ru(DDTC)3]).
Figure 3. Tris(diethyldithiocarbamato)ruthenium(III) ([Ru(DDTC)3]).
Ijms 22 12294 g003
Ijms 22 12294 g004 550
Figure 4. TEM images of RuS1.7 nanodots (a) and PEG-dBSA-RuS1.7 nanoclusters (b) [53].
Figure 4. TEM images of RuS1.7 nanodots (a) and PEG-dBSA-RuS1.7 nanoclusters (b) [53].
Ijms 22 12294 g004
Ijms 22 12294 g005 550
Figure 5. (a) Structures of thermos-responsive polymers. (b) Illustration of volume phase transition of PNINAM.
Figure 5. (a) Structures of thermos-responsive polymers. (b) Illustration of volume phase transition of PNINAM.
Ijms 22 12294 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Paca, A.M.; Ajibade, P.A. Metal Sulfide Semiconductor Nanomaterials and Polymer Microgels for Biomedical Applications. Int. J. Mol. Sci. 2021, 22, 12294. https://doi.org/10.3390/ijms222212294

AMA Style

Paca AM, Ajibade PA. Metal Sulfide Semiconductor Nanomaterials and Polymer Microgels for Biomedical Applications. International Journal of Molecular Sciences. 2021; 22(22):12294. https://doi.org/10.3390/ijms222212294

Chicago/Turabian Style

Paca, Athandwe M., and Peter A. Ajibade. 2021. "Metal Sulfide Semiconductor Nanomaterials and Polymer Microgels for Biomedical Applications" International Journal of Molecular Sciences 22, no. 22: 12294. https://doi.org/10.3390/ijms222212294

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop